UK national cohort of anal cancer treated with intensity-modulated radiotherapy: One-year oncological and patient-reported outcomes.

•Significant improvements in pain, blood in stool and health anxiety at one-year.•No significant deterioration in bowel or urinary symptoms.•Moderate male and female sexual dysfunction reported.•94% one-year overall survival in a national cohort following anal cancer (chemo)IMRT.